Adverse events grade 2+ reported in >5% of patients, classified according to NCI-CTCAE version 5.0. Adverse events are presented as related or not related according to the investigator’s judgment. Infections are presented in detail. CNS, central nervous system; NCI-CTCAE, National Cancer Institute-Common Terminology Criteria for Adverse Events.